The roles of sex hormone and gender difference for spinal cord protection in spinal cord ischemia
The roles of sex hormone and gender difference for spinal cord protection in spinal cord ischemia
批准号:
21591970
负责人:
IIDA Hiroki
金额:
$2.83万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We evaluated the tissue oxygen partial pressure of spinal cord(PsptO2) following aortic cross-clamping and-unclamping, and then clarified the mechanism of improvement in the PsptO2 following spinal ischemia observed with remote ischemic preconditioning(RIPC) or intravenous estrogen in rabbits. In isoflurane anesthetized rabbits(n=36), we prepared for measurement of PsptO2 following aortic cross-clamping using tissue PO2 monitoring. In the first set of experiment, we allocated 18 animals into 3 groups,(a) control group ; n=6,(b) RIPC group ; n=6,(c) glibenclamide pretreatment(0. 3mg/kg) group ; n=6. In the second set of experiment, we also allocated 18 animals into 3 groups,(d) control group ; n=6,(e) estrogen(17ss estradiol : 20μg) group ; n=6,(f) fulvestrant pretreatment(1mg/kg) group ; n=6. RIPC improved deterioration of the values in PsptO2 at 20 min after aortic cross-clamping and 0, 2, 5 min after aortic unclamp. The improvement was diminished by pretreatment of glibenclamide. Administration of 17s estradiol improved deterioration of the values in PsptO2 at 20 min after aortic cross-clamping and 0, 2, 5 min after aortic unclamp. The improvement was diminished by pretreatment of fulvestrant.In conclusion, after aortic cross-clamping, the RIPC performed improves the deterioration in PsptO2 through the KATP channel activation and 17ss estradiol improves the deterioration in PsptO2 through the estrogen receptor activation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
プロタミン投与後にアナフィラキシー様ショックを起こした症例
服用鱼精蛋白后过敏性休克一例
DOI:
--
发表时间:
2012
期刊:
臨床麻酔
影响因子:
--
作者:
[山田忠則, 鬼頭和裕, 太田宗一郎, 大畠博人, 飯田宏樹]
通讯作者:
飯田宏樹
術中に用いるオピオイドの種類によるベクロニウム使用料の比較
不同手术期间使用的阿片类药物类型的维库溴铵使用费用比较
DOI:
--
发表时间:
2012
期刊:
麻酔
影响因子:
--
作者:
[長瀬清, 飯田宏樹]
通讯作者:
飯田宏樹
周術期禁煙
围手术期戒烟
DOI:
--
发表时间:
2011
期刊:
臨床麻酔
影响因子:
--
作者:
[飯田宏樹, 加藤真有美]
通讯作者:
加藤真有美
Midazolam suppresses interleukin1 ss-induced interleukin-6 release from rat glial cells
咪达唑仑抑制大鼠神经胶质细胞中白细胞介素 1 SS 诱导的白细胞介素 6 释放
DOI:
--
发表时间:
2011
期刊:
J Neuroinflammation
影响因子:
--
作者:
[Tanabe K, Kozawa O, Iida H.]
通讯作者:
Iida H.
Preconditioning with estrogen lmproves the deterioration of the tissue oxygen partial pressure of spinal cord after Aortic Cross-Clamping
雌激素预处理改善主动脉阻断术后脊髓组织氧分压恶化
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Takenaka M, Iida M, Iida H.]
通讯作者:
Iida H.
共 51 条
Development of Asymmetric Polymer Catalysts Based on Controlled Helical Structure
-
批准号:23750123
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$3.0万
-
财政年份:2011
-
负责人:IIDA Hiroki
-
依托单位:
Analysis of intracellular mechanisms and related factors regarding spinal protection by remote preoonditioning
-
批准号:18591697
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.27万
-
财政年份:2006
-
负责人:IIDA Hiroki
-
依托单位:
CHANGES IN CEREBROSPINAL MLCROC1RCULATION DURING AND AFTER ABDOMINAL AORTIC CROSS-CLAMPIN : AN UNDERLYING MECHANISM
-
批准号:13671570
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2001
-
负责人:IIDA Hiroki
-
依托单位:
EFFECTS OF ALPHA2-ADRENERGIC AGONISTS AND NMDA-ANTAGONISTS ON CEREBRAL MICROCIRCULATION UNDER THE HYPOTHERMIC CONDITION -ASSESSED WITH CLOSED CRANIAL WINDOW TECHNIQUE-.
-
批准号:11671489
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.66万
-
财政年份:1999
-
负责人:IIDA Hiroki
-
依托单位:
EFFECTS OF NMDA-ATAGONISTS AND ALPHA2-ADRENERGIC AGONISTS ON SPINAL AND CEREBRAL MICROCIRCULATION -ASSESSED WITH CLOSED SPINAL AND CRANIAL WINDOW TECHNIQUE-.
-
批准号:09671555
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1997
-
负责人:IIDA Hiroki
-
依托单位:
Studies on the effects of alpha-agonist and Ca antagonist for maintaining cerebral blood flow after cardiopulmonary resuscitation.
-
批准号:06671513
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.77万
-
财政年份:1994
-
负责人:IIDA Hiroki
-
依托单位:
海外基金